Currently holds a position at Catalyst Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Financial Officer, Vice President, Treasurer | Catalyst Pharmaceuticals Inc | Dec. 16, 2011 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-12-12 | 2023-12-11 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
30,000
-27.1%
13.74412,200 USD |
30,000 -27.1% | 13.74 | 412,200 USD | |
2023-12-12 | 2023-12-08 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
20,000
-28.3%
14.30286,000 USD |
20,000 -28.3% | 14.30 | 286,000 USD | |
2023-12-12 | 2023-12-08 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
20,000
-22.1%
14.25285,000 USD |
20,000 -22.1% | 14.25 | 285,000 USD | |
2023-03-30 | 2023-03-29 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
10,000
-16.5%
16.67166,700 USD |
10,000 -16.5% | 16.67 | 166,700 USD | |
2023-03-30 | 2023-03-29 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
20,000
-24.8%
16.70334,000 USD |
20,000 -24.8% | 16.70 | 334,000 USD | |
2023-03-30 | 2023-03-29 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
20,000
-19.9%
16.72334,400 USD |
20,000 -19.9% | 16.72 | 334,400 USD | |
2023-03-30 | 2023-03-28 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
10,000
-16.5%
16.37163,700 USD |
10,000 -16.5% | 16.37 | 163,700 USD | |
2023-03-30 | 2023-03-28 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
10,000
-14.2%
16.52165,200 USD |
10,000 -14.2% | 16.52 | 165,200 USD | |
2023-03-30 | 2023-03-28 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
10,000
-12.4%
16.55165,500 USD |
10,000 -12.4% | 16.55 | 165,500 USD | |
2023-03-30 | 2023-03-28 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
28,216
-25.9%
16.60468,386 USD |
28,216 -25.9% | 16.60 | 468,386 USD | |
2022-11-23 | 2022-11-22 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
120,000
-81.4%
16.531,983,240 USD |
120,000 -81.4% | 16.53 | 1,983,240 USD | |
2022-11-17 | 2022-11-15 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
60,000
-28.9%
15.77946,080 USD |
60,000 -28.9% | 15.77 | 946,080 USD | |
2022-09-26 | 2022-09-23 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
60,000
-22.4%
11.90713,940 USD |
60,000 -22.4% | 11.90 | 713,940 USD | |
2022-09-20 | 2022-09-16 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
90,000
-25.2%
13.501,214,640 USD |
90,000 -25.2% | 13.50 | 1,214,640 USD | |
2022-09-16 | 2022-09-14 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
50,000
-12.3%
15.57778,650 USD |
50,000 -12.3% | 15.57 | 778,650 USD | |
2022-08-30 | 2022-08-29 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
17,000
-4.0%
14.28242,760 USD |
17,000 -4.0% | 14.28 | 242,760 USD | |
2022-08-30 | 2022-08-29 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
20,000
-4.5%
14.20284,000 USD |
20,000 -4.5% | 14.20 | 284,000 USD | |
2022-08-30 | 2022-08-29 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
20,000
-4.3%
14.14282,800 USD |
20,000 -4.3% | 14.14 | 282,800 USD | |
2022-08-30 | 2022-08-26 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
11,095
-2.3%
14.40159,768 USD |
11,095 -2.3% | 14.40 | 159,768 USD | |
2022-08-19 | 2022-08-18 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
19,259
-3.9%
13.70263,848 USD |
19,259 -3.9% | 13.70 | 263,848 USD | |
2022-08-19 | 2022-08-17 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
31,425
-6.2%
13.87435,890 USD |
31,425 -6.2% | 13.87 | 435,890 USD | |
2022-08-19 | 2022-08-17 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
99,316
-17.3%
13.851,375,745 USD |
99,316 -17.3% | 13.85 | 1,375,745 USD |